July 7, 2010 Chemaphor Issues Shares in Satisfaction of Interest
June 28, 2010 Chemaphor Announces OximunolTM Chewables Commercialization Plan
June 23, 2010 Chemaphor gets Commercial, Healthcare and Animal Health Experience Boost: Amin Khalifa Joins the Board as Co-Chair
June 21, 2010 Chemaphor Launches into Stem Cell Therapy Market in Canada Through Acquisition
June 14, 2010 Chemaphor Announces OximunolTM Chewables Development Update
February 1, 2010 Chemaphor Announces Positive Results of Pilot Canine Clinical Trial of an OximunolTM Supplement
January 27, 2010 Chemaphor Project Chosen to Receive a Share of Government of Canada Investment in R&D to Drive Growth in Atlantic Canada
January 6, 2010 Chemaphor Issues Shares in Satisfaction of Interest
November 11 2009 Chemaphor Raises Additional Funds in Private Placement
October 23, 2009 Chemaphor Raises Funds in Private Placement
September 28, 2009 Chemaphor Intends to Complete Private Placement
September 2009 BIOTECanada Chemaphor Article: Animal Immune System get a Boost from Biotechnology
August 24, 2009 Chemaphor Announces a Second Contribution Agreement with NRC-IRAP
August 19, 2009 Chemaphor and NRC-INH Receive Funding Support for Joint Research from PEI Government
August 12, 2009 Chemaphor Announces Formation of Expert Business and Technology Advisory Team
August 10, 2009 Chemaphor Developing a Food Animal and Companion Animal Product Platform
August 6, 2009 Chemaphor and Elanco End Relationship
July 23, 2009 NRC-IRAP Announces Contribution to Chemaphor
June 22, 2009 Chemaphor Announces Agreement with Allied Biotech Corporation
April 30, 2009 Chemaphor Completes Private Placement
April 20, 2009 Chemaphor Announces Option Grants
April, 9 2009 Chemaphor Announces a Contribution Agreement with NRC-IRAP
March 2, 2009 Chemaphor Announces Launch of Specialty Chemicals Business
February 24, 2009 Chemaphor Provides Business Update, Financial Results, and Status of Private Placement
November 21, 2008 Chemaphor Announces Proposed Private Placement
September 30, 2008 Chemaphor Announces Appointment of Dr. Paul Dick as Director
September 10, 2008 Chemaphor Appoints Dr. Paul Dick as Chief Executive Officer
July 23, 2008 Chemaphor Announces Option Grants
April 24, 2008 Election of New Director
December 27, 2007 Elanco Exercises Commercial Rights
September 12, 2007 Chemaphor Receives Intial Proceeds under OxBC Research with Elanco
May 28, 2007 Chemaphor Receives National Biotechnology Award For Promising Early Stage Company
April 25, 2007 Updates on Business at Annual General Meeting
March 27, 2007 Q1/2007 Financial Results
February 28, 2007 Financial Results for Year Ended October 31 2006
February 2, 2007 Christopher Newman appointed to Scientific Advisory Board and Mark Goudie as Director
January 12, 2007 Chemaphor Announces Proposed Private Placement Terms
December 8, 2006 Chemaphor Reaches Commercialization Agreement with Elanco
September 29, 2006 Corporate Update and Q3 Results
August 24, 2006 Chemaphor Reaches Agreement with Atlantic Canada Opportunities Agency
June 15, 2006 Positive Results for Feed Additives in Animals
May 2, 2006 Chief Financial Operator Appointed Correction
May 2, 2006 Chief Financial Operator Appointed
March 31, 2006 Chemaphor to be Offered $2.1 Million Contribution by Atlantic Canada Opportunities Agency
October 28, 2005 Chemaphor Retains Evoloution Group Inc. to assist with its Financial Communication Program
August 5, 2005 Successful Amalgamation Chemaphor begins Trading Today